Menu
Home >> NIPERs

NIPERs

National Institute of Pharmaceutical Education & Research

Indian Pharma Industry has been a global leader in Generic drugs. In order to acquire leadership position in drug discovery and development and to continue to excel in the formulations, Government recognized that human resources/talent pool is very critical. Thus Government of India has set up National Institute of Pharmaceutical Education & Research (NIPER) at SAS Nagar Mohali as a registered society under the Society Registered Act 1860, Subsequently the Institute was given statutory recognition by an act of Parliament, NIPER Act, 1998 and the Institute declared as an Institute of National Importance.

During 2007-08, six new NIPERs were started at Ahmedabad, Guwahati, Hajipur, Hyderabad, Kolkata and Raebareli with the help of Mentor Institute as under:

NIPER Mentor Institute Academic Session Started
NIPER, Mohali - 1998
NIPER, Ahmedabad B V Patel PERD Center, Ahmedabad 2007
NIPER, Guwahati Guwahati Medical College, Guwahati 2008
NIPER, Hajipur Rajendra Memorial Research Institute of Medical Science (RMRIMS-Patna) under ICMR 2007
NIPER, Hyderabad CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad 2007
NIPER, Kolkata CSIR-Indian Institute of Chemical Biology, Kolkata 2007
NIPER, Raebareli CDIR-Central Drug Research Institute, Lukhnow 2008

With appointment of regular Directors in all NIPERs, presently all these institutes are functioning independently.

The main objectives of NIPER are as under:-

  • Nurture and promote quality and excellence in pharmaceutical education and research:
  • Run Master's, Doctoral and post-Doctoral courses and research in pharmaceutical education
  • Develop a multi-disciplinary approach in carrying out research and training of pharmaceutical manpower ; and
  • Act as nucleus for interaction between academic and industry by undertaking sponsored and funded research as well as consultancy projects

Admission Procedure in NIPERs:

At present these NIPERs impart Ph.D and PG level education and grant degree under the NIPER Act, 1998. The students are selected through a common entrance examination. Each Master student is given a fellowship of Rs. 12,400/- per month and Ph.D scholars @ Rs. 31,000-35,000/-.

1. NIPER, MOHALI

NIPER, SAS Nagar, Mohali was initially registered as a society under the Societies Act. The faculty for the institute was appointed in 1994. In 1998, Parliament enacted National Institute of Pharmaceutical Education and Research Act, 1998. NIPER was declared as an “Institute of National Importance” under the Act of Parliament on 26th June 1998. NIPER is a member of Association of Indian Universities.

Disciplines:

The first batch of students was admitted in 1998. NIPER offers Masters'and Ph.D. degrees in 15 streams and caters to the various needs of pharmaceutical industry:

  1. Medicinal Chemistry
  2. Natural Products
  3. Traditional Medicine
  4. Pharmaceutical Analysis
  5. Pharmacology & Toxicology
  6. Regulatory Toxicology
  7. Pharmaceutical Technology (Biotechnology)
  8. Pharmaceutical Technology (Formulations)
  9. Pharmaceutical Technology (Process Chemistry)
  10. Pharmaceutics
  11. Biotechnology
  12. Pharmacy Practice
  13. Clinical Research
  14. Pharmacoinformatics
  15. Pharmaceutical Management

Student's details:

2019
Course Enrolled Pass-out
M.S (Pharm) 207 199
M.B.A 44 42
Ph.D 16 09
Total 267 250

Academic excellence

In 2018, the Institute has published 118 articles in journals of repute. NIPER has filed 3 patents and 12 patents have been granted in 2018. Since the inception of academic programme (till August 2019), 3008 students have passed out (Masters 2228, MBA 522 & Ph.D. 258)

Teacher-Student ratio:-

Course Ratio
2018-2019
Ph. D. (111:29)- 3.83:1
Masters' (Science) 389:29
MBA (Pharm.) 82:3

* Guest faculty members are also taking classes

Research:-

  1. Neglected diseases- Research is carried out in the areas of tuberculosis, leishmaniasis and malaria. New molecules are being synthesized and their mechanisms of action are being worked out.
  2. Other diseases Metabolic pathways in diseases like inflammation, infection, cancer, diabetes, neurodegeneration are being worked out.
  3. Drug development and formulation
    1. Improvement of oral bioavailability, synergistic anticancer efficacy and reduced toxicity of drugs has been attempted.
    2. New formulations are being developed.
  4. Other Areas
    1. Chemo-enzymatic synthesis of drugs
    2. Monograph on herbals is being developed.
    3. Study of the effect of RNA aptamers on stabilization of misfolded proteins
    4. Assessment of an appropriate and reliable method to diagnose neuropathic pain

Innovation / knowledge transfer

  1. Patents and Commercialisation: 190 (filed)/81 (granted)/08 (licensed) till date
  2. Citation per faculty: 798

Institution leadership

  1. Ranked #3 in the category ‘Pharmacy’ in NIRF MHRD 2019 Rankings
  2. Recognized as one of the four institutes in the country with AAAA+ ranking by Career360 magazine (Outlook group) (March 2018)
  3. Recognized as among the top 100 Indian Innovator companies and research organizations (2014) (Thomson Reuters
  4. Chosen as one of the destinations (apart from USA and UK) by Government of Kazakhstan for award of Bolashak scholarship to its nationals to pursue research programme in pharmaceutical sciences
  5. Member, WHO Expert advisory panel on the International Pharmacopoeia and Pharmaceutical Preparations; Advisor, WHO expert committee on specifications for pharmaceutical preparations; Member Scientific Body, IPC

Impact of NIPER

The success of NIPER, S.A.S. Nagar has encouraged the GoI to set up more NIPERs across the country to meet the growing demands of the pharmaceutical sector. In addition, NIPER has carried out training programmes for personnel from India and abroad under ITEC-SCAAAP, capacity building programmes (World Bank-sponsored) and SMPIC. Participation in rebuilding of public sector enterprises like IDPL, BCPL, HAL, etc. Training and analytical services provided to small and medium-scale enterprises (SMEs): Setting up of a centre for SMEs. Member of committee evaluating ‘Investigational New Drugs’ (IND) applications. Member of committee revising Indian pharmacopeia. Contribution of monographs to Ayurvedic pharmacopeia of India Carried out study on “Impact of TRIPS on pharmaceutical prices with special focus on generics in India”, under the work plan of WHO biennium and MHFW (GOI)

2. NIPER- Ahmedabad

NIPER Ahmedabad was established in the year 2007. Since its inception, the institute was functioning under Mentor Institute B.V. Patel PERD Centre up to 31st July 2016. From 01st August, 2016 it has started functioning independently at its own campus at Palaj, Gandhinagar in temporary building with a state of art research laboratory facility including animal house. Board of Governors (BoG) of NIPER-Ahmedabad has been constituted on 09.03.2019.

Discliplnes:

NIPER offers Masters' and Ph.D. degrees in 7 streams and caters to the various needs of pharmaceutical industry:

  1. Natural Products
  2. Pharmaceutics
  3. Biotechnology
  4. Medicinal Chemistry
  5. Pharmaceutical Analysis
  6. Pharmacology and Toxicology
  7. Medical Device

Sanctioned strength of staff, in position and vacancy position:

The Institute presently functioning with contractual faculty/staff, Recently 33 faculty and 25 non-faculty posts have been created with the approval of Department of Expenditure in January 2019. The RRs have been framed and the posts have been advertised which are likely to be filled shortly.

Students details:

2019
Course Enrolled Pass-out
M.S (Pharm) 112 72
Ph.D 12 04
Total 124 76

Academic excellence

In 2018, the Institute has published 130 articles in journals of repute. NIPER has filed 3 patents in 2018. Since the inception of academic programme (till August 2019), 517 students have passed out (Masters 511, & Ph.D. 06).

Teacher-Student ratio:

Presently1: 15 (14 Faculty : 208 students)

Research:

  1. Active Research Areas:

  2. Diabetes, Cancer, Neurodegenerative Disease, Infectious diseases, Tissue repair, regeneration and Medical Implants.

  3. Publications:

  4. 363 Total, 130 (Year 2018)

  5. Poster Presentation:

  6. 55(Year 2017)

Innovation & Knowledge transfer

03 Patent has been filed in 2018.

Impact of NIPER :

NIPER Ahmedabad would serve as a good launching platform to revamp the pharma education and research, to initiate the new era of pharmaceutical and biomedical sciences. NIPER-Ahmedabad lays its commitment in building human resource for promoting research and development in the country and contribute towards ‘'Make in India'' initiative as a part of its national responsibility

The Institute has outreached to fetch scholars with excellent postdoctoral and teaching experiences from all over the world to enrich the education and research quality of the institute. With these exceptional faculties, the Institute motivates its students to achieve the highest standards of excellence in their courses.

NIPER-Ahmedabad has achieved a path of growth and development and attained ALL INDIA RANK # 1 in TLR (teaching, learning, and research) and in OI (outreach and inclusivity) with overall Rank #09 in NIRF-2019 ranking of MHRD.

NIPER-Ahmedabad has established itself as one of the top technological pharmacy research institutes in the country with research collaboration as an integral part of the growth strategy. NIPER Ahmedabad has expanded its outreach to the industry as well as collaborated with the best academic institution of USA, UK, Australia, Ireland and Malaysia for collaborating research, faculty visit, syllabus up-gradation and regulatory reforms with several industries and leading institutes.

NIPER Ahmedabad has actively committed to promote research and stimulate scientific cross talk across various disciplines. It has conducted various conferences, symposiums, discussions on chemistry, biology, medicine and materials attended by masters' students, Ph.D, post docs and researchers from academia and industry. The discussions are scientifically stimulating and have led to healthy cross talks and collaborations.

3. NIPER Guwahati

NIPER Guwahati started functioning from 2008 under Mentor Institute Guwahati Medical College Guwahati, Assam (up to 31 July 2017). After appointment of regular Director the Institute is running independently. From 1st August 2017, NIPER-Guwahati is functioning from the NITS-Mirza Campus. Board of Governors of NIPER-Guwahati has been constituted vide order dated 09.03.2019.

Disciplines:

NIPER offers Masters’ and Ph.D. degrees in 3 streams and caters to the various needs of pharmaceutical industry

  1. Pharmacology & Toxicology
  2. Pharmacy Practice
  3. Biotechnology.
  4. Pharmaceutical Analysis.
  5. Pharmaceutics.

Sanctioned strength of staff, in position and vacancy position:

The Institute presently functioning with contractual faculty/staff, Recently 33 faculty and 25 non-faculty posts have been created with the approval of Department of Expenditure in January 2019. The RRs have been framed and the 11 faculty posts and 08 non-faculty posts have been advertised which are likely to be filled shortly.

Students Details

2019
Course Enrolled Pass-out
M.S (Pharm) 72 39
Ph. D. 11 -
Total 83 39

Academc excellence:

In 2018, the Institute has published 17 articles in journals of repute. NIPER has filed 2 patents in 2018. Since the inception of academic programme (till August 2019), 332 students have passed out (Masters 324, & Ph.D. 08).

Teacher-Student ratio:

  • Biotechnology: 1:5
  • Pharmacology and Toxicology: 1:8
  • Pharmacy Practice: 1:5
  • Pharmaceutics: 1:8
  • Pharmaceutical Analysis: 1:8

Research:

BIOTECHNOLOGY :

  • Development of Biopharmaceuticals using Biomolecular Engineering/Synthetic Biology approaches -
  • Oncogenic mRNA cleaving Deoxyribozymes;
  • Development of new approaches of Immune rerouting for targeting cancer cells;
  • Development of new approaches of Immune rerouting for targeting cancer cells;
  • Generation of random Protein coding sequences & Aptamer based therapeutics and diagnostic tools.
  • Investigation on Genomics and Proteomics to study various diseases like Multiple Myeloma, Acute Myeloid leukemia, Chronic Myeloid leukemia, Myodisplastic syndrome, Ischemia-Stroke disorder, Neuropathic Pain, etc.

PHARMACOLOGY AND TOXICOLOGY:

  • Molecular Pharmacology;
  • Development of Cancer targeted drug delivery systems;
  • Screening Indian biodiversity and Indian Systems of Medicine in search of newer compounds in the area of inflammation, arthritis, diabetes, cancer and hepatoprotective activities;
  • Targeting RANKL for the treatment of inflammation and cancer induced bone disorders.
  • Screening of NCE's & North-East plant products for anti-Parkinson's and antidepressant effects.
  • Studies on the mitigation of drug induced toxicities through natural products derived from Northeast India.

PHARMACY PRACTICE

  1. Study of drug utilization pattern for antiepileptic and antipsychotic drugs.
  2. Impact of Lipodystrophy on Quality of Life, Social and Psychological Aspects in PLHIV on First line and Second line Anti Retroviral regimen
  3. Haemovigilance: An important tool for improving safe blood transfusion practices

Innovation & Knowledge transfer:

The institute is currently in the process of submitting one patent application in the area of Biopharmaceuticals. It will be further explored for its commercial value.

Impact of NIPER:

The establishment of NIPER-Guwahati has given a strong boost to the promotion of Pharmaceutical Education & Research in the North East region of India. Research efforts of NIPER Guwahati have revived the studies on medicinal value of local herbs of North East Region against various diseases.

NIPER-Guwahati has organized a National conference entitled “Ethno-medicine and Traditional Health Practices in Northeast region of India” in collaboration with the Society for Ethno pharmacology (SFE), India, on 25th August 2018. This conference focussed on several contemporary issues of drug discovery & development from medicinal and aromatic plants together with their quality evaluation, validation and safety related aspects.

NIPER-Guwahati played a pivotal role in a grand assembly of plant-derived medicine practitioners (Traditional Healers living in the North-East states of India) on 26th August 2018 at NIPER-Guwahati premises. Around 76 traditional healers from Assam, Mizoram, Meghalaya, Sikkim and Tripura attended this meet and showcased their plant-derived medicinal products in individual stalls.

The faculty members of NIPER-Guwahati have been awarded 06 Extramural projects in the year 2018 from different funding agencies like DBT, DST, DRDO, Ministry of Environment, Forest and Climate Change, etc.

NIPER-Guwahati is the only NIPER to have a Synthetic Biology Laboratory, which has been awarded ‘Genome Editing Task Force’ project by DBT, Govt. of India. 100% MS(Pharm) and M. Pharm. admissions during this academic year (2018-19) reflects the growing reputation and the stature of NIPER-Guwahati among the Students and the Industrial counterparts. The Institute has entered into several MoUs with leading Research institutes, Hospitals and Pharmaceutical Industries to give students and faculty the best of the academic and research support to eventually come up with technologies and products for the benefit of the society.

4. NIPER Hajipur

NIPER Hajipur started functioning in 2007 under Mentor Institute Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna. After appointment of regular Director the Institute is running independently. Board of Governor of NIPER-Hajipur has been constituted vide DoP’s order dated 09.03.2019.

Disciplines:

NIPER offers Masters' and Ph.D. degrees in 3 streams and caters to the various needs of pharmaceutical industry:

  1. Biotechnology
  2. Pharmacy Practice
  3. Pharmacoinformatics

Sanctioned strength of staff, in position and vacancy position:

The Institute presently functioning with contractual faculty/staff, Recently 19 faculty and 25 non-faculty posts have been created with the approval of Department of Expenditure in January 2019. The RRs have been framed and the posts are likely to be filled shortly.

Students detail:

2019
Course Enrolled Pass-out
M.S (Pharm) 49 23
Ph. D. 05 01
Total 54 24

Academic excellence:-

In 2018, the Institute has published 08 articles in journals of repute. Since the inception of academic programme (till August 2019), 294 students have passed out (Masters 286, & Ph.D. 08).

Teacher-Student ratio: 1:10

Research

Biotechnology

  • Development of novel drugs against Kala zaar (Leishmaniasis) targeting epigenetic factors and DNA repair pathway.
  • Development of non-invasive tool for early detection of breast cancer
  • Development of Novel therapeutic strategies against HIV
  • Application of functionalized and conjugated gold Nanoparticles for improved antimicrobial efficacy

Pharmacoinformatics

  • Identification of novel inhibitors for cysteine synthase enzyme for Leishmania donovani. Using structure based pharmacophore models, Molecular dynamics studies and virtual screening methods.
  • Development of novel inhibitors for G-Protein Coupled Receptor 3(GPR3) for the treatment of Alzheimer's disease (AD) using QM docking studies, homology modelling, molecular dynamics (MD) studies, free energy calculation studies.

Pharmacy Practice

  • HPV and associated clinical outcomes in cervical cancer
  • Association among periostin, testosterone and obesity with the incidence of osteoporosis in elderly male type 2 diabetic patients
  • Assessment of sex hormones (estrogen and testosterone) in type 2 diabetes mellitus patients under oral hypoglycemic drugs
  • Assessment of periostin in post menopausal thyroid patients and finding relationship with osteoporosis
  • To evaluate the ADR of imatinib with reference to p210 and p190 fusion transcripts in chronic myloidleukemia patients.

Impact of NIPER:

NIPER Hajipur has successfully produced 294 students in three disciplines namely, Biotechnology, Pharmacoinformatics and Pharmacy Practice who are either employed in different pharmaceutical industries or pursuing their higher education in different institutes or universities across the globe. Many of NIPER Hajipur ex-students are engaged as faculty at different institutions.

5. NIPER Hyderabad

NIPER Hyderabad started functioning in 2007 under Mentorship of Institute Indian Institute of Chemical Technology, CSIR-IICT, Hyderabad. After appointment of regular Director the Institute is running independently. Board of Governors of NIPER-Hyderabad has been constituted vide DoP’s order dated 09.03.2019.

Disciplines:

NIPER offers Masters' and Ph.D. degreesin 7 streams and caters to the various needs of pharmaceutical industry:

  1. Medicinal Chemistry
  2. Pharmaceutical Analysis
  3. Pharmacology & Toxicology
  4. Pharmaceutics
  5. Pharmaceutical Management
  6. Pharmaceutical Technology (Process Chemistry)
  7. Regulatory Toxicology

Sanctioned strength of staff, in position and vacancy position:

The Institute presently functioning with contractual faculty/staff, Recently 33 faculty and 25 non-faculty posts have been created with the approval of Department of Expenditure in January 2019. The RRs have been framed and 18 faculty posts and 08 non-faculty posts have been advertised which are likely to be filled shortly.

Students details:

2019
Course Enrolled Pass-out
M.S (Pharm) 149 120
Ph. D. 18 01
Total 167 121

Academic excellence:-

In 2018, the Institute has published 100 articles in journals of repute. Since the inception of academic programme (till August 2019), 969 students have passed out (Masters, 932& Ph.D. 37).

Teacher-Student ratio

Presently 1: 18 (18 Faculty: 330 students include juniors, seniors and PhD students)

Core Research areas:

  • Integrated Drug Discovery & Product Development Programmes
    1. Cancer, Inflammation and related proliferative diseases
    2. Diabetes and other metabolic disorders
    3. Infectious diseases
    4. Psoriasis
  • In vitro and in vivo screening
  • In vitro and in vivo screening
  • Development of Analytical Methods, Impurity Profiling and Stability studies
  • Solid state characterization

Innovation / knowledge transfer

  1. Patents and commercialization- 12 patents filed in areas of Cancer Drug Discovery, Formulation Development and Analytical Method Development
  2. Research income earned from Industry - 22 Lakhs
  3. Citation per faculty- Average 320 citations per faculty

Impact of NIPER:

NIPER Hyderabad has transformed itself to be a world class institute of teaching and research in Pharmaceutical Sciences and Management. The Institute has set up fruitful collaborations with various organizations nationally and internationally. Innovative areas of research are explored every year in emerging segments driven by the research expansion motive.

About, 932 students were awarded MS (Pharm)/M.Tech (Pharm)/MBA (Pharm) degrees and 37 Ph.D. degrees were awarded by NIPER. NIPER has around 32 sponsored projects from various government and private funding agencies and industries. One of the objectives of NIPER-Hyderabad is development of Human Resources for the ever growing Indian Pharmaceutical Industry. NIPER-Hyderabad is on the forefront in placement activities and received recognition globally. The placement record of NIPER Hyderabad stands at ~90% and our students are serving at various major pharmaceutical companies.

In 2019, NIPER Hyderabad bagged 6th position in the country among 500 best research institutions in NIRF ranking by MHRD and 481 rank among 5,000 research institutions and universities from across the world in the recent release of Scimago Institutions Rankings (SIR). The ranking was based on three primary criteria - Innovation, Research and Societal Impact.

NIPER is communicating and sharing event information, conferences - reports / photos / videos of events, MOU signed, Guest lectures and Make India programs - content relating to public engagement through social media like Face book and Twitter. Every month NIPER-H is preparing report based on social media outcome from twitter and face book.

6. NIPER Kolkata

NIPER, Kolkata is presently housed at the Indian Institute of Chemical Biology (IICB) – a premier Institute of the Council of Scientific & Industrial Research (CDRI), India, which is the Mentor Institute. After appointment of regular Director the Institute is running independently. Board of Governors of NIPER-Kolkata has been constituted vide DoP’s order dated 09.03.2019.

Disciplines:

NIPER offers Masters' and Ph.D. degrees in 3 streams and caters to the various needs of pharmaceutical industry:

  1. Medicinal Chemistry
  2. Natural Products
  3. Phamacoinformatics

Sanctioned strength of staff, in position and vacancy position:

The Institute presently functioning with contractual faculty/staff, Recently 19 faculty and 25 non-faculty posts have been created with the approval of Department of Expenditure in January 2019. The RRs have been framed and 07 faculty and 08 non-faculty posts have been advertised which are likely to be filled shortly.

Students details:

2019
Course Enrolled Pass-out
M.S (Pharm) 32 44
Ph. D. 01 02
Total 33 46

Academic excellence:

In 2018, the Institute has published 18 articles in journals of repute. Since the inception of academic programme (till August 2019), 452students have passed out (Masters, 450 & Ph.D. 02).

Teacher-Student ratio: 1:11

Research:

  1. Active Research Areas: Synthetic and plant based drug discovery, immunology and immune diagnostics, cellular and molecular biology, recombinant DNA technology and monoclonal antibody technology, novel drug delivery systems, chemical and biochemical process technology, etc.
  2. Innovation & Knowledge transfer:111 Nos. Research papers have been published in renowned international journals from the project work of the MS (Pharm.) students since inception to till date.

Impact of NIPER:

  1. A total of 452 highly knowledged students have been graduated.
  2. 247 students are engaged to work in companies/institutions.
  3. 111 Research papers have been published.
  4. 3 numbers of MS (Pharm.) second year students have undergone their project work in M/s Sanofi India Pvt. Limited. During their 3 months training monthly stipend were paid by the M/s Sanofi India Pvt. Ltd.
  5. M.S. (Pharm.) students of NIPER-Kolkata stood 1st & 2nd position in the National Eligibility Test for Ph.D. course admission conducted by NIPER-Mohali continuously two years 2016-17 & 2017-18

7. NIPER- RAIBARELI

NIPER-Raebareli started functioning in 2008 under the mentorship of CSIR-Central Drug Research Institute, Lucknow. After appointment of regular Director the Institute is running independently. Board of Governors of NIPER-Raebareli has been constituted vide DoP’s order dated 09.03.2019.

Disciplines:

NIPER offers Masters' and Ph.D. degrees in 3 streams and caters to the various needs of pharmaceutical industry:

  1. Medicinal Chemistry
  2. Pharmaceutics
  3. Pharmacology and Toxicology

Sanctioned strength of staff, in position and vacancy position:

The Institute presently functioning with contractual faculty/staff, Recently 19 faculty and 25 non-faculty posts have been created with the approval of Department of Expenditure in January 2019. The RRs have been framed and 09 faculty posts and 10 non-faculty posts have been advertised which are likely to be filled shortly.

2019
Course Enrolled Pass-out
M.S (Pharm) 65 37
Ph. D. 07 -
Total 72 37

Academic excellence:-

In 2018, the Institute has published 24 articles in journals of repute. Since the inception of academic programme (till August 2019), 329 students of masters have passed out.

Teacher-Student ratio

Course Ratio
Ph. D. 1:1
M.S (Pharm) 1:9

Research

The various R & D activities currently in progress and/or planned at NIPER, Raebareli are as follows-

  • Design and development of drugs/drug intermediate for the treatment of inflammatory and oxidative stress.
  • Study of bioavailability related issues and for site specific/targeted drug delivery.
  • Development and evaluation of drugs/formulations for heavy metal toxicity like arsenic.
  • Safety studies of nanoparticle based materials like, metallic gold, zinc, copper etc.

Impact of NIPER:

  • Created excellent human resource by imparting high quality education in pharmaceutical sciences.
  • Served as an excellent research institute by focusing on thrust areas of national and international relevance.
  • Faculty have published research papers and reviews and also chapters in books in highly rated journals and international publications like Elsevier/ Springer etc.
National Institute of Pharmaceuticals Education and Research (NIPERs) Contact List
S.No. Responsibility Centers and Subordinate Landline Number Email Mobile Number Address
1. Prof. A. Raghuram Rao NIPER-Mohali 0172-2214690 0172-2214697 director[at]niper[dot]ac[dot]in 8790432456 SAS Nagar, NIPER Mohali, Punjab - 160062
2. Dr. Kiran Kalia, NIPER-Ahmedabad 079-66745555 kirankalia[at]gmail[dot]com
director[at]niperahm[dot]ac[dot]in
9714618573 Palaj Opp. Air Force Station Head Quarter, Gandhinagar-382355, Gujarat.
3. Dr. Shashi Bala Singh NIPER-Hyderabad 040-23073741 director[dot]niperhyd[at]gov[dot]in, director[at]niperhyd[dot]ac[dot]in 09999297992 NIPER, Hyderabad IDPL Township, Balangar, Hyderabad-500007
4. Dr. Gayathri V. Patil NIPER-Hajipur 0612-2631565 patilgayathri[at]yahoo[dot]co[dot]in, niper[dot]hajipur2007[at]gmail[dot]com 8600376332 E.P.I.P. Campus, Industrial Area, Hajipur-844102, Bihar
5. Dr.V. Ravichandiran, NIPER-Kolkata 033-24995803 033-23200086 director[at]niperkolkata[dot]edu[dot]in 09443963481 Chunilal Bhawan, 168, Maniktala main road, Kolkata-700054, West Bangal
6. Dr. USN Murty NIPER-Guwahati 0361-2132751 murtyusn[at]gmail[dot]com, murty_usn[at]yahoo[dot]com, director[at]niperguwahati[dot]ac[dot]in 9127060998 C/o NITS-Mirza Santipur, Parlli Part, NH-37 Mirza, Kamrup, Assam - 781 125
7. Dr. SJS Flora NIPER-Raebareli 0535-2700851 sjsflora[at]hotmail[dot]com director[at]niperraebareli[dot]edu[dot]in 9425482305 Bijnor-Sisendi Road, Sarojini Nagar, Near CRPF Base Camp, Luknow (UP) - 226002
English
Min Description: 
Nurturing Quality & Excellence in Pharma Education and Research